Insiders / Myles David C.

Myles David C.

CIK 1831216personinsider

Companies

1

First seen

Jan 14, 2026

Last activity

Feb 4, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Olema Pharmaceuticals, Inc. · OLMA	Executive	687,607	592,761	11	—

All securities held

3 positions · latest reported per filing

Company	Security	Shares	As of
Olema Pharmaceuticals, Inc.	Common Stock	687,607	Jan 14, 2026
Olema Pharmaceuticals, Inc.	Stock Option (Right to Buy)Derivative	250,000	Feb 2, 2026
Olema Pharmaceuticals, Inc.	Performance Stock Options (Right to Buy)Derivative	106,250	Feb 2, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jan 13, 2026	Sell	OLMA Olema Pharmaceuticals, Inc. Common Stock	$1.37M	-50K -8.40%	542,961 0.62% of shares	medium
Jan 14, 2026	Sell	OLMA Olema Pharmaceuticals, Inc. Common Stock	$1.01M	-35K -6.06%	542,761 0.62% of shares	medium
Jan 14, 2026	Sell	OLMA Olema Pharmaceuticals, Inc. Common Stock	$428.9K	-15K -2.53%	577,764 0.66% of shares	medium
Jan 12, 2026	Sell	OLMA Olema Pharmaceuticals, Inc. Common Stock	$283.4K	-10K -6.46%	144,846 0.17% of shares	medium
Jan 14, 2026	Exercise	OLMA Olema Pharmaceuticals, Inc. Common Stock	$243.5K	+50K +9.21%	592,761 0.68% of shares	low
Jan 13, 2026	Exercise	OLMA Olema Pharmaceuticals, Inc. Common Stock	$243.5K	+50K +9.21%	592,761 0.68% of shares	low
Jan 13, 2026	Sell	OLMA Olema Pharmaceuticals, Inc. Common Stock	$5.7K	-200 -0.04%	542,761 0.62% of shares	low
Feb 2, 2026	Grant	OLMA Olema Pharmaceuticals, Inc. Performance Stock Options (Right to Buy)	—	+106K	106,250 0.12% of shares	low
Feb 2, 2026	Grant	OLMA Olema Pharmaceuticals, Inc. Stock Option (Right to Buy)	—	+250K	250,000 0.29% of shares	low
Jan 14, 2026	Exercise	OLMA Olema Pharmaceuticals, Inc. Stock Option (Right to Buy)	—	-50K -50.00%	50,000 0.06% of shares	low